Previous 10 | Next 10 |
2024-01-10 08:20:42 ET More on Amgen Amgen Inc. (AMGN) Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024 (Transcript) Amgen: Wonderful Stock At Decent Price Amgen: Bet On Its Breakthrough Drug Pharma and biotech deal values spike 35% in 2023: rep...
2024-01-09 10:25:55 ET Palm Beach, FL – January 9, 2024 – According to the report titled “Aging in the United States,” published by the Population Reference Bureau, “the number of Americans aged 65 and older is projected to increase more than double over 9...
2024-01-09 01:07:03 ET Summary Xeris Biopharma Holdings focuses on developing and commercializing therapies in endocrinology, neurology, and gastroenterology using their proprietary formulation platforms. Their formulation platforms, XeriSol and XeriJect, address limitations of aq...
2024-01-08 15:34:35 ET Summary Number of years left before retirement is an important factor to consider when planning investments, as it determines what is the best strategy to compound wealth. Young investors should focus on investing in durable businesses with high-quality earn...
2024-01-08 15:32:08 ET Amgen Inc. (AMGN) J.P. Morgan 42nd Annual Healthcare Conference 2024 January 08, 2024, 12:00 AM ET Company Participants Robert Bradway - Chairman & CEO Conference Call Participants Chris Schott - J.P. Morgan Presentation ...
2024-01-06 09:22:48 ET Summary Johnson & Johnson is a Dividend King focused on the creation and manufacturing of medical devices, vaccines, and medicines. Sales of Darzalex, an anti-CD38 monoclonal antibody, were $2.5 billion in the third quarter of 2023, up 21.8% year-over-ye...
2024-01-05 18:07:09 ET Summary I express frustration with the constant negativity surrounding the idea that beating the market is impossible for the average investor. I share my personal success in beating the market in 2023, with a time-weighted return of 28.02%. I emphasize ...
2024-01-05 09:07:57 ET More on Big Pharma Bristol-Myers Squibb Company (BMY) Management presents at Goldman Sachs Healthcare C-Suite Unscripted Conference (Transcript) Merck & Co., Inc. (MRK) Goldman Sachs Healthcare C-Suite Unscripted Conference (Transcript) Bri...
2024-01-05 10:17:57 ET More on Big Pharma Bristol-Myers Squibb Company (BMY) Management presents at Goldman Sachs Healthcare C-Suite Unscripted Conference (Transcript) Merck & Co., Inc. (MRK) Goldman Sachs Healthcare C-Suite Unscripted Conference (Transcript) Bri...
2024-01-04 13:29:38 ET Summary Johnson & Johnson's stock has underperformed the market, but its strong performance and secure balance sheet make it an attractive investment during uncertainty. The company's Q3 results showed solid growth, and it raised its full-year outlook, p...
News, Short Squeeze, Breakout and More Instantly...
2024-07-18 10:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-15 07:58:00 ET Can a biotechnology company pay a generous dividend in 2024? The answer is definitely yes, as Amgen (NASDAQ: AMGN) is evidently unafraid to reward its loyal shareholders with quarterly cash payments. Just as importantly, Amgen is a recent revenue growe...
2024-07-14 06:30:00 ET Income investors don't have to settle for dividends that tread water. There are plenty of stocks to buy that offer growing dividends and are poised to keep the momentum going along with attractive dividend yields . Three Motley Fool contributors think they've ...